Greek track sprinter positive in re-analysis of 2016 Olympics samples

Christos Volikakis on the podium of the Men's Scratch Race during the 2019 UCI Track Cycling World Cup in Hong Kong
Christos Volikakis on the podium of the Men's Scratch Race during the 2019 UCI Track Cycling World Cup in Hong Kong (Image credit: Getty Images)

The UCI announced that it has provisionally suspended Greek track sprinter Christos Volikákis, 36, after he tested positive for an experimental drug, Ligandrol (LGD-4033), in the re-analysis of doping controls taken at the 2016 Olympic Games in Rio de Janeiro, Brazil.

Ligandrol is a selective androgen receptor modulator (SARM), a class of drugs that activate androgen receptors, providing the same benefits as anabolic steroids without the side effects on reproductive organs. SARMs are prohibited substances under class S1.2 (Other Anabolic Agents) of the Prohibited List.

Thank you for reading 5 articles in the past 30 days*

Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read any 5 articles for free in each 30-day period, this automatically resets

After your trial you will be billed £4.99 $7.99 €5.99 per month, cancel anytime. Or sign up for one year for just £49 $79 €59

Join now for unlimited access

Try your first month for just £1 / $1 / €1

Laura Weislo
Managing Editor

Laura Weislo has been with Cyclingnews since 2006 after making a switch from a career in science. As Managing Editor, she coordinates coverage for North American events and global news. As former elite-level road racer who dabbled in cyclo-cross and track, Laura has a passion for all three disciplines. When not working she likes to go camping and explore lesser traveled roads, paths and gravel tracks. Laura specialises in covering doping, anti-doping, UCI governance and performing data analysis.